-
1دورية أكاديمية
المؤلفون: Hendry AJ; National Centre for Immunisation Research and Surveillance, the Children's Hospital at Westmead, Sydney, NSW., Quinn HE; National Centre for Immunisation Research and Surveillance, the Children's Hospital at Westmead, Sydney, NSW.; The University of Sydney, Sydney, NSW., Macartney K; National Centre for Immunisation Research and Surveillance, the Children's Hospital at Westmead, Sydney, NSW.; The University of Sydney, Sydney, NSW., Beard FH; National Centre for Immunisation Research and Surveillance, the Children's Hospital at Westmead, Sydney, NSW.; The University of Sydney, Sydney, NSW.
المصدر: The Medical journal of Australia [Med J Aust] 2024 Aug 19; Vol. 221 (4), pp. 224-225. Date of Electronic Publication: 2024 Jul 17.
نوع المنشور: Letter; Journal Article
بيانات الدورية: Publisher: Australasian Medical Publishing Co Country of Publication: Australia NLM ID: 0400714 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1326-5377 (Electronic) Linking ISSN: 0025729X NLM ISO Abbreviation: Med J Aust Subsets: MEDLINE
مواضيع طبية MeSH: Vaccination Coverage*/statistics & numerical data , Diphtheria*/prevention & control , Diphtheria*/epidemiology , Registries* , Whooping Cough*/prevention & control , Whooping Cough*/epidemiology , Tetanus*/prevention & control , Tetanus*/epidemiology, Humans ; Australia/epidemiology ; Aged ; Female ; Male ; Aged, 80 and over ; Diphtheria-Tetanus-Pertussis Vaccine/administration & dosage ; Tetanus Toxoid/administration & dosage ; Pertussis Vaccine/administration & dosage
-
2دورية أكاديمية
المؤلفون: Hasegawa S; Division of Infectious Diseases, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, USA. Electronic address: shinya-hasegawa@uiowa.edu., Simpson R; Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City, IA, USA., Oladele-Ajose A; Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, USA., Sekar P; Division of Infectious Diseases, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
المصدر: The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Jul; Vol. 24 (7), pp. e472.
نوع المنشور: Case Reports; Journal Article
بيانات الدورية: Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE
مواضيع طبية MeSH: Tetanus*/complications, Humans ; Male ; Diabetic Neuropathies ; Middle Aged ; Tetanus Toxoid/administration & dosage
-
3دورية أكاديمية
المؤلفون: Wanlapakorn N; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Sarawanangkoor N; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Srimuan D; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Thatsanathorn T; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Thongmee T; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Poovorawan Y; Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.; The Academy of Science, The Royal Society of Thailand, Bangkok, Thailand.
المصدر: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2352909. Date of Electronic Publication: 2024 May 16.
نوع المنشور: Comparative Study; Journal Article
بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE
مواضيع طبية MeSH: Antibodies, Bacterial*/blood , Bordetella pertussis*/immunology , Diphtheria-Tetanus-Pertussis Vaccine*/immunology , Diphtheria-Tetanus-Pertussis Vaccine*/administration & dosage , Haemophilus influenzae type b*/immunology , Haemophilus Vaccines*/immunology , Haemophilus Vaccines*/administration & dosage , Immunization, Secondary* , Vaccines, Combined*/immunology , Vaccines, Combined*/administration & dosage , Whooping Cough*/prevention & control , Whooping Cough*/immunology, Child, Preschool ; Female ; Humans ; Infant ; Male ; Diphtheria/prevention & control ; Diphtheria/immunology ; Diphtheria Toxoid/immunology ; Diphtheria Toxoid/administration & dosage ; Diphtheria-Tetanus-acellular Pertussis Vaccines/immunology ; Diphtheria-Tetanus-acellular Pertussis Vaccines/administration & dosage ; Haemophilus Infections/prevention & control ; Haemophilus Infections/immunology ; Poliovirus Vaccine, Inactivated/immunology ; Poliovirus Vaccine, Inactivated/administration & dosage ; Tetanus Toxoid/immunology ; Tetanus Toxoid/administration & dosage ; Thailand ; Follow-Up Studies
-
4دورية أكاديمية
المؤلفون: Richmond P; University of Western Australia School of Medicine, Department of Immunology, Perth Children's Hospital and Telethon Kids Institute, Nedlands, WA, Australia., Nolan T; Vaccine and Immunisation Research Group (VIRGo), Peter Doherty Institute for Infection and Immunity at the University of Melbourne and Murdoch Children's Research Institute, Melbourne, VIC, Australia., McGirr A; Northern Beaches Clinical Research, Brookvale, NSW, Australia., Napier-Flood F; Paratus Clinical Research Western Sydney, Blacktown, NSW, Australia., Kim J; Paratus Clinical Research Central Coast, Kanwal, NSW, Australia., Leah A; Paratus Clinical Research Canberra, Bruce, ACT, Australia., Xie F; Dynavax Technologies Corporation, Emeryville, CA, USA., Campbell JD; Dynavax Technologies Corporation, Emeryville, CA, USA., Godeaux O; ZAM Consulting, Brussels, Belgium., Henry O; Dynavax Technologies Corporation, Emeryville, CA, USA., Wood N; Kids Research, The Children's Hospital at Westmead, Westmead, NSW, Australia., Janssen RS; Dynavax Technologies Corporation, Emeryville, CA, USA. Electronic address: rjanssen@dynavax.com.
المصدر: Vaccine [Vaccine] 2024 Oct 24; Vol. 42 (24), pp. 126251. Date of Electronic Publication: 2024 Sep 02.
نوع المنشور: Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial; Multicenter Study; Comparative Study
بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
مواضيع طبية MeSH: Antibodies, Bacterial*/blood , Immunization, Secondary*/methods , Diphtheria-Tetanus-acellular Pertussis Vaccines*/immunology , Diphtheria-Tetanus-acellular Pertussis Vaccines*/administration & dosage , Diphtheria-Tetanus-acellular Pertussis Vaccines*/adverse effects , Adjuvants, Immunologic*/administration & dosage , Adjuvants, Immunologic*/adverse effects , Oligodeoxyribonucleotides*/administration & dosage , Oligodeoxyribonucleotides*/immunology , Whooping Cough*/prevention & control , Whooping Cough*/immunology, Humans ; Adolescent ; Female ; Male ; Adult ; Young Adult ; Child ; Antibodies, Neutralizing/blood ; Diphtheria-Tetanus-Pertussis Vaccine/immunology ; Diphtheria-Tetanus-Pertussis Vaccine/administration & dosage ; Diphtheria-Tetanus-Pertussis Vaccine/adverse effects ; Tetanus/prevention & control ; Tetanus/immunology ; Healthy Volunteers ; Immunogenicity, Vaccine
-
5دورية أكاديمية
المؤلفون: Kanu FA; Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States; The U.S. Public Health Service Commissioned Corps, Atlanta, Georgia, United States. Electronic address: fkanu@cdc.gov., Freeland C; Hepatitis B Foundation, Doylestown, Pennsylvania, United States., Nwokoro UU; Department of Community Medicine, University of Nigeria Teaching Hospital, Enugu, Nigeria; African Field Epidemiology Network, Abuja, Nigeria., Mohammed Y; African Field Epidemiology Network, Abuja, Nigeria; Department of Medical Microbiology and Parasitology, College of Health Sciences, Usmanu Danfodiyo University, Sokoto, Nigeria., Ikwe H; Global Immunization Division, CDC-Nigeria, Abuja, Nigeria., Uba B; African Field Epidemiology Network, Abuja, Nigeria; National Emergency Routine Immunization Coordination Centre, Abuja, Nigeria., Sandhu H; Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States., An Q; Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States., Asekun A; Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States; Global Immunization Division, CDC-Nigeria, Abuja, Nigeria., Akataobi C; African Field Epidemiology Network, Abuja, Nigeria; National Stop Transmission of Poliomyelitis, Nigeria., Adewole A; African Field Epidemiology Network, Abuja, Nigeria; National Stop Transmission of Poliomyelitis, Nigeria., Fadahunsi R; African Field Epidemiology Network, Abuja, Nigeria; National Stop Transmission of Poliomyelitis, Nigeria., Wisdom M; African Field Epidemiology Network, Abuja, Nigeria; National Stop Transmission of Poliomyelitis, Nigeria., Akudo OL; African Field Epidemiology Network, Abuja, Nigeria; National Stop Transmission of Poliomyelitis, Nigeria., Ugbenyo G; African Field Epidemiology Network, Abuja, Nigeria; National Stop Transmission of Poliomyelitis, Nigeria., Simple E; African Field Epidemiology Network, Abuja, Nigeria; National Stop Transmission of Poliomyelitis, Nigeria., Waziri N; African Field Epidemiology Network, Abuja, Nigeria; National Stop Transmission of Poliomyelitis, Nigeria., Vasumu JJ; Adamawa State Primary Health Care Development Agency, Yola, Adamawa, Nigeria., Bahuli AU; Adamawa State Primary Health Care Development Agency, Yola, Adamawa, Nigeria., Bashir SS; Adamawa State Primary Health Care Development Agency, Yola, Adamawa, Nigeria., Isa A; Adamawa State Primary Health Care Development Agency, Yola, Adamawa, Nigeria., Ugwu G; Department of Obsterics and Gynaecology, College of Medicine, University of Nsukka, Nsukka, Enugu, Nigeria; Enugu State Primary Health Care Development Agency, Enugu, Nigeria., Obi EI; National Emergency Routine Immunization Coordination Centre, Abuja, Nigeria., Binta H; National Emergency Routine Immunization Coordination Centre, Abuja, Nigeria; College of Medicine, University of Nigeria Teaching Hospital, Enugu, Nigeria., Bassey BO; National Primary Health Care Development Agency, Abuja, Nigeria., Shuaib F; National Primary Health Care Development Agency, Abuja, Nigeria., Bolu O; Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States., Tohme RA; Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States.
المصدر: Vaccine [Vaccine] 2024 Oct 24; Vol. 42 (24), pp. 126222. Date of Electronic Publication: 2024 Aug 27.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
مواضيع طبية MeSH: Hepatitis B*/prevention & control , Hepatitis B Vaccines*/administration & dosage , Hepatitis B Vaccines*/immunology , Tetanus*/prevention & control , Pregnant Women* , Vaccination Coverage*/statistics & numerical data, Humans ; Female ; Pregnancy ; Nigeria ; Infant, Newborn ; Vaccination/statistics & numerical data ; Vaccination/methods ; Adult ; Health Personnel ; Prenatal Care/methods ; Tetanus Toxoid/administration & dosage ; Tetanus Toxoid/immunology ; Immunization Programs ; Pregnancy Complications, Infectious/prevention & control
-
6دورية أكاديمية
المؤلفون: Zhu Y; Management of Immunization programmes, Hebei Province Center for Disease Prevention and Control, Shijiazhuang, P.R. China., Sun L; Management of Immunization programmes, Hebei Province Center for Disease Prevention and Control, Shijiazhuang, P.R. China., Wang Y; Management of Immunization programmes, Hebei Province Center for Disease Prevention and Control, Shijiazhuang, P.R. China., Wang J; Management of Immunization programmes, Hebei Province Center for Disease Prevention and Control, Shijiazhuang, P.R. China., Wang Y; Management of Immunization programmes, Hebei Province Center for Disease Prevention and Control, Shijiazhuang, P.R. China., Li J; Management of Immunization programmes, Hebei Province Center for Disease Prevention and Control, Shijiazhuang, P.R. China., Wang L; Management of Immunization programmes, Hebei Province Center for Disease Prevention and Control, Shijiazhuang, P.R. China., Guo Y; Management of Immunization programmes, Hebei Province Center for Disease Prevention and Control, Shijiazhuang, P.R. China.
المصدر: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2372884. Date of Electronic Publication: 2024 Jul 03.
نوع المنشور: Journal Article; Comparative Study
بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE
مواضيع طبية MeSH: Haemophilus Vaccines*/adverse effects , Haemophilus Vaccines*/administration & dosage , Poliovirus Vaccine, Inactivated*/adverse effects , Poliovirus Vaccine, Inactivated*/administration & dosage , Diphtheria-Tetanus-Pertussis Vaccine*/adverse effects , Diphtheria-Tetanus-Pertussis Vaccine*/administration & dosage , Vaccines, Combined*/adverse effects , Vaccines, Combined*/administration & dosage, Humans ; Infant ; China/epidemiology ; Female ; Male ; Vaccination/adverse effects ; Haemophilus Infections/prevention & control ; Immunization Schedule ; Drug-Related Side Effects and Adverse Reactions/epidemiology ; Diphtheria-Tetanus-acellular Pertussis Vaccines/adverse effects ; Diphtheria-Tetanus-acellular Pertussis Vaccines/administration & dosage
-
7دورية أكاديمية
المؤلفون: Lima CP; Laboratory of Biopharmaceuticals, Butantan Institute, Sao Paulo 05503-900, Brazil.; Interunits Graduate Program in Biotechnology, University of Sao Paulo, Sao Paulo 05508-270, Brazil., Barreiros GM; Laboratory of Biopharmaceuticals, Butantan Institute, Sao Paulo 05503-900, Brazil.; Interunits Graduate Program in Biotechnology, University of Sao Paulo, Sao Paulo 05508-270, Brazil., Oliveira ASA; Laboratory of Biopharmaceuticals, Butantan Institute, Sao Paulo 05503-900, Brazil., de Souza MM; CENTD-Centre of Excellence in New Target Discovery, Butantan Institute, São Paulo 05503-900, Brazil., Manieri TM; Laboratory of Biopharmaceuticals, Butantan Institute, Sao Paulo 05503-900, Brazil.; CeRDI-Center for Research and Development in Immunobiologicals, Butantan Institute, São Paulo 05503-900, Brazil., Moro AM; Laboratory of Biopharmaceuticals, Butantan Institute, Sao Paulo 05503-900, Brazil.; CeRDI-Center for Research and Development in Immunobiologicals, Butantan Institute, São Paulo 05503-900, Brazil.
المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 May 26; Vol. 25 (11). Date of Electronic Publication: 2024 May 26.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
مواضيع طبية MeSH: Neurons*/metabolism , Antibodies, Monoclonal*/immunology , Endocytosis* , Tetanus Toxin*/immunology , Tetanus Toxin*/metabolism , Molecular Docking Simulation*, Animals ; Rats ; Humans ; Tetanus/prevention & control ; Tetanus/immunology ; Epitopes/immunology ; Gangliosides/immunology ; Gangliosides/metabolism ; Cells, Cultured ; Computer Simulation ; Metalloendopeptidases
-
8دورية أكاديمية
المؤلفون: Karkhaneh F; Institute for Convergence Science & Technology, Islamic Azad University Science and Research Branch, Tehran, Iran., Sadr ZK; Institute for Convergence Science & Technology, Islamic Azad University Science and Research Branch, Tehran, Iran., Rad AM; Institute for Convergence Science & Technology, Islamic Azad University Science and Research Branch, Tehran, Iran., Divsalar A; Faculty of Biological Science, Kharazmi University, Tehran, Iran.
المصدر: Biomedical physics & engineering express [Biomed Phys Eng Express] 2024 May 24; Vol. 10 (4). Date of Electronic Publication: 2024 May 24.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: IOP Publishing Ltd Country of Publication: England NLM ID: 101675002 Publication Model: Electronic Cited Medium: Internet ISSN: 2057-1976 (Electronic) Linking ISSN: 20571976 NLM ISO Abbreviation: Biomed Phys Eng Express Subsets: MEDLINE
مواضيع طبية MeSH: Tetanus Toxoid*/chemistry , Tetanus Toxoid*/immunology , Silanes*/chemistry , Biosensing Techniques*/methods , Propylamines*/chemistry, Spectroscopy, Fourier Transform Infrared ; Humans ; Enzyme-Linked Immunosorbent Assay ; Magnetic Iron Oxide Nanoparticles/chemistry ; Tetanus/diagnosis ; Tetanus/prevention & control ; Magnetite Nanoparticles/chemistry ; Antibodies, Immobilized/chemistry ; Antibodies, Immobilized/immunology ; Limit of Detection ; Iron/chemistry ; Agglutination Tests/methods
-
9دورية أكاديمية
المؤلفون: Nakano T; Professor, Department of Pediatrics, Kawasaki Medical School, Japan., Hasegawa M; Mitsubishi Tanabe Pharma Corporation, Japan., Endo M; Mitsubishi Tanabe Pharma Corporation, Japan., Matsuda K; Clinical Development Department, Clinical Development Section, The Research Foundation for Microbial Diseases of Osaka University, Japan. Electronic address: clinicaldevelopment@mail.biken.or.jp., Tamai H; Clinical Development Department, Clinical Development Section, The Research Foundation for Microbial Diseases of Osaka University, Japan.
المصدر: Vaccine [Vaccine] 2024 Apr 30; Vol. 42 (12), pp. 3134-3143. Date of Electronic Publication: 2024 Apr 06.
نوع المنشور: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Journal Article
بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
مواضيع طبية MeSH: Haemophilus influenzae type b* , Tetanus*/prevention & control , Diphtheria*/prevention & control , Whooping Cough*/prevention & control , Poliomyelitis*/prevention & control , Haemophilus Vaccines*, Infant ; Humans ; Japan ; Tetanus Toxin ; Diphtheria Toxin ; Poliovirus Vaccine, Inactivated ; Immunization Schedule ; Antibodies, Bacterial ; Diphtheria-Tetanus-Pertussis Vaccine ; Vaccines, Combined ; Vaccines, Conjugate
-
10دورية أكاديمية
المؤلفون: Gembe M; Department of Nursing, College of Health Science, Mattu University, Mattu, Ethiopia., Wosenyeleh T; Department of Nursing, College of Health Science, Mattu University, Mattu, Ethiopia., Gezimu W; Department of Nursing, College of Health Science, Mattu University, Mattu, Ethiopia.
المصدر: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2320501. Date of Electronic Publication: 2024 Mar 11.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE
مواضيع طبية MeSH: Tetanus*/prevention & control, Infant, Newborn ; Humans ; Female ; Pregnancy ; Ethiopia/epidemiology ; Cross-Sectional Studies ; Mothers ; Prenatal Care ; Tetanus Toxoid ; Immunization